Interventions Required to Reduce Non-Cancer-Related Hospitalizations for Elderly Men after Prostate Cancer Diagnosis, Study Finds
A new study published in the February issue of JNCCN finds that men older than 67 who are diagnosed with prostate cancer are 37 percent more likely to have non-cancer-related hospitalization after diagnosis than before diagnosis, pointing to the need to better manage non-cancer conditions after a cancer diagnosis.
FORT WASHINGTON, PA — A cancer diagnosis presents challenges in managing other existing non-cancer health conditions. In many cases, these chronic conditions may worsen until hospitalization is needed. Recently, West Virginia University researchers examined non-cancer-related hospitalizations in men diagnosed with prostate cancer and found that men age 67 or older were 37 percent more likely to be hospitalized for non-cancer reasons after cancer diagnosis than before. The study was published in the February issue of JNCCN – Journal of the National Comprehensive Cancer Network.
Full access to the article, titled, “Impact of Prostate Cancer Diagnosis on Non-Cancer Hospitalizations among Elderly Medicare Beneficiaries with Incident Prostate Cancer,” is available at JNCCN.org until April 30, 2016.
More than 220,000 men are diagnosed with prostate cancer each year in the United States, and the average age for diagnosis is 66. Many of these patients are diagnosed with prostate cancer in the early stage and have an excellent cancer-related survival profile. Therefore, the care of non-cancer conditions constitutes an important health care need even for those with prostate cancer.
“The study findings underscore the necessity of targeted research, program, policy, and intervention efforts required to reduce the incidence of non-cancer-related hospitalizations in elderly men with prostate cancer,” said lead author, Amit D. Raval, PhD, Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University. “Effective communication between oncologists and primary care physicians should be facilitated in order to design and implement individualized care programs for patients, taking into account their pre-existing conditions, in order to lead to optimal outcomes for the patient.”
The population-based retrospective cohort study was conducted using the SEER-Medicare linked database for years 2000 – 2010; the study cohort consisted of more than 57,000 men with prostate cancer who were 67 years or older. The study found the rate of hospitalization for non-cancer reasons was 37 percent higher in the time period following cancer diagnosis than before diagnosis. While the reasons for this higher rate are not certain, the authors suggest that it may be because cancer treatment distracts from other health care problems, or that stress and anxiety may make other health care problems worse.
Additional analysis demonstrated that patients with cardiac/endocrine conditions alone or combined with respiratory or mental health conditions had a greater increase in the risk of non-cancer-related hospitalizations during the post-diagnosis period compared with pre-diagnosis.
Older men diagnosed with prostate cancer appear to be susceptible to the worsening of other, non-cancer health considerations severe enough to require hospitalization following the prostate cancer diagnosis. Coordination of care and management of both cancer and non-cancer health care problems may maintain health and reduce the need for more frequent hospitalizations.
To access the JNCCN article, visit JNCCN.org. Full access to the article is available until April 30, 2016.
###
About JNCCN – Journal of the National Comprehensive Cancer Network
More than 23,000 oncologists and other cancer care professionals across the United States read JNCCN–Journal of the National Comprehensive Cancer Network. This peer-reviewed, indexed medical journal provides the latest information about best clinical practices, health services research, and translational medicine. JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), review articles elaborating on guidelines recommendations, health services research, and case reports highlighting molecular insights in patient care. JNCCN is published by Harborside Press. Visit JNCCN.org. For a COMPLIMENTARY subscription to JNCCN, visit http://www.nccn.org/jnccn/subscribe.asp
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients.
Katie Kiley Brown, NCCN
215.690.0238
Tags:
